Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate | Zendy

Christine E. MacBrayne | Zendy; Kristen Marks | Zendy; Daniel S. Fierer | Zendy; Susanggie | Zendy; Raymond T. Chung | Zendy; Michael D. Hughes | Zendy; Arthur Y. Kim | Zendy; Marion G. Peters | Zendy; Diana M. Brainard | Zendy; Sharon M. Seifert | Zendy; José CastilloMancilla | Zendy; Lane R. Bushman | Zendy; Peter L. Anderson | Zendy; Jennifer J. Kiser | Zendy

Open Access

Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate

Author(s) -

Christine E. MacBrayne,

Kristen Marks,

Daniel S. Fierer,

Susanggie,

Raymond T. Chung,

Michael D. Hughes,

Arthur Y. Kim,

Marion G. Peters,

Diana M. Brainard,

Sharon M. Seifert,

José CastilloMancilla,

Lane R. Bushman,

Peter L. Anderson,

Jennifer J. Kiser

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky146

Subject(s) - sofosbuvir , medicine , ledipasvir , pharmacokinetics , ribavirin , cohort , gastroenterology , pharmacology , hepatitis c virus , hepatitis c , tenofovir , virology , human immunodeficiency virus (hiv) , virus

The nucleotide analogues tenofovir and sofosbuvir are considered to have low potential for drug interactions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research